The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Prevalence of risk factors in men with premature coronary artery disease
Abstract
The prevalence of modifiable cardiovascular risk factors (systemic hypertension, diabetes mellitus, cigarette smoking, low-density lipoprotein [LDL] cholesterol greater than or equal to 160 mg/dl and high-density lipoprotein [HDL] cholesterol less than 35 mg/dl) was determined in 321 men less than 60 years of age (mean +/- standard deviation 50 +/- 7) with premature coronary artery disease (CAD) documented at coronary angiography. The prevalence of these risk factors was markedly different than in the Framingham Offspring Study population, used here as a comparison group. In the patients with CAD, only 3% had no risk factor (other than male sex), compared with 31% in the Framingham Offspring Study subjects. Most patients with CAD (97%) had greater than or equal to 1 additional risk factor. When the patients with CAD were divided by age groups (40 to 49 years [n = 109], 50 to 59 [n = 191]), no significant differences were observed in the prevalence of risk factors between the young and older patients. The prevalence of systemic hypertension (41 vs 19%, p less than 0.001), diabetes mellitus (12 vs 1.1%, p less than 0.001), cigarette smoking (67 vs 28%, p less than 0.001) and HDL cholesterol less than 35 mg/dl (63 vs 19%, p less than 0.001) was markedly higher in the patients with CAD than in Framingham Offspring Study subjects, whereas the prevalence of LDL cholesterol greater than or equal to 160 mg/dl was not significantly different between patients with CAD and Framingham Offspring Study subjects (26 vs 26%).(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with manifest CHD frequently exhibit low HDL cholesterol (HDL-C) [2].”
From HDL cholesterol: reappraisal of its clinical relevance (2017) · cites this paper as [2]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,458
Multiple Risk Factor Intervention Trial
Michel, D. (1982) · JAMA · doi:10.1001/jama.1982.03330120023025 · Cited by 2,211
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Clofibrate and Niacin in Coronary Heart Disease
Stamler, J. (1975) · JAMA · doi:10.1001/jama.1975.03240160024021 · Cited by 1,750
Quantitative Effects of Dietary Fat on Serum Cholesterol in Man
Hegsted, D. M., McGandy, R. B., Myers, M. L., & Stare, F. J. (1965) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/17.5.281 · Cited by 1,589
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
The Lipid Research Clinics Coronary Primary Prevention Trial Results
(1984) · JAMA · doi:10.1001/jama.1984.03340270043026 · Cited by 1,404
Research works printed but not linked: 2
- 1988, Can Med Assoc J, 138, 1
- Warnick, 1982, Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol, Clin Chem, 79, 93
Cited by
Sorted by citations
Items 201–244 of 244
Choi, Y. J., Choi, S. H., Kim, H. J., Han, S. J., Hwang, J. S., Chung, Y., Lee, K. W., Cho, H. K., & Kim, D. J. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.4.534 · Cited by 2
Kawabata, F., & Tsuji, T. (2011) · Japanese Journal of Complementary and Alternative Medicine · doi:10.1625/jcam.8.55 · Cited by 2
High-Density Lipoprotein Cholesterol and Triglycerides in Coronary Heart Disease Risk Assessment
Miller, M. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00009-8 · Cited by 2
Obesity and Dyslipidemia: Importance of Body Fat Distribution
Tchernof, A., & Després, J. (2009) · Wiley eBooks · doi:10.1002/9781444307627.ch13 · Cited by 2
MOLECULAR MECHANISMS IN OBESITY- ASSOCIATED METABOLIC DISEASE
Olofsson, L. E. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
HDL Inflammation and Atherosclerosis: Current and Future Perspectives
Sampietro, T., Bigazzi, F., Puntoni, M., & Bionda, A. (2005) · Future Cardiology · doi:10.2217/14796678.2.1.37 · Cited by 2
Tareen, A. K., Achakzai, A. S., Cheema, L. A., Ali, A. M., & Rehman, M. A. (2012) · Pakistan Heart Journal · Cited by 1
Zacharias, E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3326-2_11 · Cited by 1
RECENT PATTERN OF CORONARY ARTERY DISEASE AND ITS RISK FACTORS: COMPARISION IN GENDER AND AGE GROUPS
Shah, A. U., Amin, B., Shahzeb, M., Tayyeb, M., Khan, A., Ahmad, N., Imran, M. A., Ahmad, S., & Ahmad, A. (2023) · Journal of Khyber College of Dentistry · doi:10.33279/jkcd.v13i04.30 · Cited by 1
Supari, S. F., Raharjo, S. B., Liastuti, L. D., & Basha, A. (2007) · Medical Journal of Indonesia · doi:10.13181/mji.v16i3.273 · Cited by 1
Review of Ten Biomarkers of Coronary Artery Diseases
Ghassab, R. K. (2016) · Focus on Sciences · doi:10.20286/focsci-020112 · Cited by 1
Raising high-density lipoprotein cholesterol for better prevention of cardiovascular disease
Birjmohun, R. S., Stroes, E. S. G., & Kastelein, J. J. P. (2006) · Future Lipidology · doi:10.2217/17460875.1.1.47 · Cited by 1
High-density lipoprotein cholesterol: ready for prime time?
Yc, K. (2005) · PubMed · Cited by 1
High-Density Lipoprotein Cholesterol in Coronary Heart Disease Risk Assessment
Miller, M. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50014-7 · Cited by 1
Atherosclerosis: Cholesterol Management
Edmondson, S. D., Burnett, D. A., & Davis, H. R. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc185.pub2 · Cited by 1
Obesity and Dyslipidaemia: Importance of Body Fat Distribution
Tchernof, A., & Després, J. (2005) · Wiley eBooks · doi:10.1002/9780470987087.ch12 · Cited by 1
Remaley, A. T., & Warnick, G. R. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400085 · Cited by 1
Altersabhängige Veränderungen des hämostaseologischen Risikoprofils aus kardiologischer Sicht
Plehn, G., Jax, T. W., Leschke, M., Meißner, A., & Trappe, H. (2009) · Der Kardiologe · doi:10.1007/s12181-009-0204-3
Lean red meat and lean white meat in the ncep step i diet
Maki, K. C., & Davidson, M. H. (2000) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-000-0023-0
Cimmino, G., D’Amico, C., Ciccarelli, G., Golino, M., Morello, A., D’Elia, S., Marchese, V., & Golino, P. (2013) · Cardiogenetics · doi:10.4081/cardiogenetics.2013.e7
High-density lipoproteins: the guardian angel of the cell membrane
Ferretti, G., Bacchetti, T., Masciangelo, S., & Bertoli, E. (2009) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-009-0032-z
Myocardial Infarction in the Younger Patient
Fang, J. C.-T., & Plutzky, J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-351-4_22
Razão triglicerídios / HDL-colesterol como preditor do perfil de subclasses de lipoproteínas
Toé, D., & Fernandes, T. (2007) · Americanae (AECID Library)
Petto, J., Vasques, L. M. R., Vasques, R. O., Pinheiro, R. L. S., Giesta, B. D. A., Carlos, A. D., dos Santos, N., Neto, M. G., & Marice, A. (2014)
Treatment of Vulnerable Plaques
Brieger, D. B., Freedman, S., Kritharides, L., & Lowe, H. C. (2004) · CRC Press eBooks · doi:10.1201/9781420037883.ch10
Lisinopril for the Treatment of Hypertension in Aviators
Rhodes, D. B., & Howe, B. (1999) · doi:10.21236/ada361212
Organizing Services for Organizing Services for Cardiovascular Prevention Cardiovascular Prevention
Block, R., & Pearson, T. A. (2007)
Prevalencia de la hipertensión en la diabetes mellitus
Muñoz, M. E., Arbaje, Z. G., & Báez, A. F. (1992) · Ciencia y Sociedad · doi:10.22206/cys.1992.v17i2.pp131-40
Repolarization Parameters in Patients with Premature Coronary Artery Disease
Ekizler, F. A., Tak, B. T., Çay, S., Kafes, H., Özeke, Ö., Özcan, F., Aras, D., & Topaloğlu, S. (2019) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2019.63935
Wang, Y. E., Kirschke, C. P., Woodhouse, L. R., Bonnel, E. L., Stephensen, C. B., Bennett, B. J., Newman, J. W. I., Keim, N. L., & Huang, L. (2020) · doi:10.21203/rs.3.rs-94525/v1
Wang, Y. E., Kirschke, C. P., Woodhouse, L. R., Bonnel, E. L., Stephensen, C. B., Bennett, B. J., Newman, J. W. I., Keim, N. L., & Huang, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1019814/v1
(1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.3.702s
Myocardial Infarction in the Younger Patient
Plutzky, J. (1999) · Contemporary cardiology · doi:10.1007/978-1-59259-731-4_21
Thanh, K. N., Thành, T. T., Huy, T. Đ., An*, L. H., Hương, T. T., Nam, V. T. M. V., Mai, B. V. B., Nội, T. Đ. H. Y. H., Dược, K. Y., & *, Đ. H. Q. G. H. N. (2018) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.81.2018.1090
BindingDB (2009) · UC San Diego · doi:10.7270/q2vd6wt9
Black Elderberry Extract Reduces Cardiometabolic Risk by Lowering Inflammation in Mice
Farrell, N. J. (2015) · OpenCommons at University of Connecticut (University of Connecticut)
Metadata
- Authors
- Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J.
- Affiliations
- Tufts University (US)
- Corresponding author
- Schaefer, Ernst J.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1991-06
- Volume
- 67
- Issue
- 15
- Pages
- 1185-1189
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2041225533
- Cited by
- 243
- References
- 28
- Citations by year
- 2023: 2 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 8 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 9 · 2013: 6 · 2012: 10
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl035243-03)
- National Heart, Lung, and Blood Institute (HL 35243)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- premature coronary artery disease, cardiovascular risk factors, men, systemic hypertension, diabetes mellitus, cigarette smoking, LDL cholesterol, HDL cholesterol, beta-blockers, Framingham Offspring Study, National Cholesterol Education Program guidelines, triglycerides, coronary angiography, young adults, risk factor prevalence
- MeSH terms
- Adult, Coronary Disease, Diabetes Mellitus, Humans, Hypertension, Cholesterol, HDL, Cholesterol, LDL, Male, Massachusetts, Middle Aged, Risk Factors, Smoking, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review